Abbreviated Name

Pancreatic Ref Set-Hanash (2017)

Lead Investigator

Hanash, Samir — The University of Texas MD Anderson Cancer Center

Coordinating Investigator

Feng, Ziding — Fred Hutchinson Cancer Center

Involved Investigators

• Feng, Ziding — Fred Hutchinson Cancer Center
• Hanash, Samir — The University of Texas MD Anderson Cancer Center

Abstact

No abstract availalbe.

Aims

No aims available.

Analytic Method

No analytic method available.

Outcome

The pre-specified three-marker (with CA199 one of the markers) combination has comparable or slightly better AUC than CA199 for separating all cancer, early stage cancer, or late stage cancer from healthy controls, after adjusting for specimen contributing sites, although the differences are not statistically significant.

Publications

• No publications available at this time for this protocol.

Biomarkers

• APOA1
• ATP5PF
• CA19-9
• DECR2
• LRG1
• PGM3
• STK10
• TIMP1

Data Collections

• No data collections available at this time for this protocol.

 Team Project

Start Date

Jul 12 2017

Estimated Finish Date

Jul 12 2018

Finish Date

Mar 14 2019

Protocol ID

423

Protocol Type

Reference Set

Field of Research

Proteomics

Collaborative Group

G.I. and Other Associated Cancers Research Group

Cancer Types

• Malignant neoplasm of pancreas

Phased Status

1